Literature DB >> 24344309

Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.

Ya-Lin Chen1, Cheng-Der Liu, Chi-Ping Cheng, Bo Zhao, Hao-Jen Hsu, Chih-Long Shen, Shu-Jun Chiu, Elliott Kieff, Chih-wen Peng.   

Abstract

Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is essential for EBV episome maintenance, replication, and transcription. These effects are mediated by EBNA1 binding to cognate oriP DNA, which comprise 20 imperfect copies of a 30-bp dyad symmetry enhancer and an origin for DNA replication. To identify cell proteins essential for these EBNA1 functions, EBNA1 associated cell proteins were immune precipitated and analyzed by liquid chromatography-tandem mass spectrometry. Nucleolin (NCL) was identified to be EBNA1 associated. EBNA1's N-terminal 100 aa and NCL's RNA-binding domains were critical for EBNA1/NCL interaction. Lentivirus shRNA-mediated NCL depletion substantially reduced EBNA1 recruitment to oriP DNA, EBNA1-dependent transcription of an EBV oriP luciferase reporter, and EBV genome maintenance in lymphoblastoid cell lines. NCL RNA-binding domain K429 was critical for ATP and EBNA1 binding. NCL overexpression increased EBNA1 binding to oriP and transcription, whereas NCL K429A was deficient. Moreover, NCL silencing impaired lymphoblastoid cell line growth. These experiments reveal a surprisingly critical role for NCL K429 in EBNA1 episome maintenance and transcription, which may be a target for therapeutic intervention.

Entities:  

Keywords:  chromatin; lymphoma; nasopharyngeal carcinoma; oncogenic herpesvirus

Mesh:

Substances:

Year:  2013        PMID: 24344309      PMCID: PMC3890893          DOI: 10.1073/pnas.1321800111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.

Authors:  D F Ceccarelli; L Frappier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.

Authors:  Ya-Lin Chen; Hsing-Lyn Tsai; Chih-Wen Peng
Journal:  Biochem Biophys Res Commun       Date:  2011-12-27       Impact factor: 3.575

3.  Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.

Authors:  H Rafatro; D Ramanitrahasimbola; P Rasoanaivo; S Ratsimamanga-Urverg; A Rakoto-Ratsimamanga; F Frappier
Journal:  Biochem Pharmacol       Date:  2000-05-01       Impact factor: 5.858

4.  Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1972-08-09

5.  C23 interacts with B23, a putative nucleolar-localization-signal-binding protein.

Authors:  Y P Li; R K Busch; B C Valdez; H Busch
Journal:  Eur J Biochem       Date:  1996-04-01

6.  Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication.

Authors:  Blair L Strang; Steeve Boulant; Donald M Coen
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

7.  The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability.

Authors:  Dongyun Zhang; Jingxia Li; Min Zhang; Guangxun Gao; Zhenghong Zuo; Yonghui Yu; Linda Zhu; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

8.  The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.

Authors:  Ammy Lin; Shan Wang; Tin Nguyen; Kathy Shire; Lori Frappier
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

9.  Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation.

Authors:  Shan Wang; Lori Frappier
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

10.  In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

Authors:  Flavia Pichiorri; Dario Palmieri; Luciana De Luca; Jessica Consiglio; Jia You; Alberto Rocci; Tiffany Talabere; Claudia Piovan; Alessandro Lagana; Luciano Cascione; Jingwen Guan; Pierluigi Gasparini; Veronica Balatti; Gerard Nuovo; Vincenzo Coppola; Craig C Hofmeister; Guido Marcucci; John C Byrd; Stefano Volinia; Charles L Shapiro; Michael A Freitas; Carlo M Croce
Journal:  J Exp Med       Date:  2013-04-22       Impact factor: 17.579

View more
  17 in total

1.  Targeting nucleolin for better survival in diffuse large B-cell lymphoma.

Authors:  N Jain; H Zhu; T Khashab; Q Ye; B George; R Mathur; R K Singh; Z Berkova; J F Wise; F K Braun; X Wang; K Patel; Z Y Xu-Monette; J Courty; K H Young; L Sehgal; F Samaniego
Journal:  Leukemia       Date:  2017-07-10       Impact factor: 11.528

2.  Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.

Authors:  Chih-Lung Shen; Cheng-Der Liu; Ren-In You; Yung-Hao Ching; Jun Liang; Liangru Ke; Ya-Lin Chen; Hong-Chi Chen; Hao-Jen Hsu; Je-Wen Liou; Elliott Kieff; Chih-Wen Peng
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 3.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

4.  Nucleolin Promotes IRES-Driven Translation of Foot-and-Mouth Disease Virus by Supporting the Assembly of Translation Initiation Complexes.

Authors:  Shichong Han; Xiaojia Wang; Junyong Guan; Jinen Wu; Yun Zhang; Pinghua Li; Zaixin Liu; Sahibzada Waheed Abdullah; Zhihui Zhang; Ye Jin; Shiqi Sun; Huichen Guo
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription.

Authors:  Elena Tosoni; Ilaria Frasson; Matteo Scalabrin; Rosalba Perrone; Elena Butovskaya; Matteo Nadai; Giorgio Palù; Dan Fabris; Sara N Richter
Journal:  Nucleic Acids Res       Date:  2015-09-09       Impact factor: 16.971

6.  Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.

Authors:  María José Lista; Rodrigo Prado Martins; Olivier Billant; Marie-Astrid Contesse; Sarah Findakly; Pierre Pochard; Chrysoula Daskalogianni; Claire Beauvineau; Corinne Guetta; Christophe Jamin; Marie-Paule Teulade-Fichou; Robin Fåhraeus; Cécile Voisset; Marc Blondel
Journal:  Nat Commun       Date:  2017-07-07       Impact factor: 14.919

7.  The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.

Authors:  Huan Wang; Lang Bu; Chao Wang; Yaqian Zhang; Heng Zhou; Xi Zhang; Wei Guo; Cong Long; Deyin Guo; Xiaoping Sun
Journal:  Cell Death Dis       Date:  2018-06-29       Impact factor: 8.469

8.  BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.

Authors:  Matthew R Harter; Cheng-Der Liu; Chih-Lung Shen; Elsie Gonzalez-Hurtado; Zhi-Min Zhang; Muyu Xu; Ernest Martinez; Chih-Wen Peng; Jikui Song
Journal:  PLoS Pathog       Date:  2016-02-04       Impact factor: 6.823

9.  HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.

Authors:  Jayaraju Dheekollu; Andreas Wiedmer; Daniel Sentana-Lledo; Joel Cassel; Troy Messick; Paul M Lieberman
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

10.  The cellular protein nucleolin preferentially binds long-looped G-quadruplex nucleic acids.

Authors:  Sara Lago; Elena Tosoni; Matteo Nadai; Manlio Palumbo; Sara N Richter
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-11-30       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.